S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

PAM Health to Construct 42-Bed Rehabilitation Hospital in Fayetteville

With North Carolina ranking as the ninth most populous state in the U.S., PAM Health is expanding its regional footprint by launching a 42-bed physical medicine and rehabilitation center in Fayetteville. The facility aims to serve patients recovering from complex neurological, cardiac, and orthopedic conditions while creating 200 local jobs.

PAM Health to Construct 42-Bed Rehabilitation Hospital in Fayetteville
Photo: Bio & News

The upcoming Fayetteville location serves as a cornerstone of the company’s broader growth strategy, marking one of four new inpatient rehabilitation hospitals planned for the state. By integrating physical, occupational, and speech therapy, the center will provide specialized care for patients navigating recovery from traumatic brain injuries, strokes, and post-surgical complications. Anthony Misitano, founder and CEO of PAM Health, noted that the expansion reflects a commitment to patient-centered care in a rapidly developing community.

Beyond inpatient services, the hospital will offer outpatient therapy to ensure a continuous recovery path after discharge. The facility is also set to implement nationally recognized workers' compensation programs, offering a specialized return-to-work resource for the area's expanding workforce. Based in Enola, Pennsylvania, PAM Health currently operates over 100 medical and behavioral health facilities across 23 states.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!